Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials - Kakkos, S K; Kirkilesis, G I; Tsolakis, I A (Eur J Vasc Endovasc Surg, 2014)